Weekly Reports
Updates for the week ending March 29, 2013
The list below will link directly to documents on the BCSC website. Please use your browser's BACK button to return to this page.
Policies and Instruments
- 81-102 - CSA Notice and Request for Comment – Proposed Amendments to National Instrument 81-102 Mutual Funds, Companion Policy 81-102CP Mutual Funds and Related Consequential Amendments - and Other Matters concerning National Instrument 81-104 Commodity Pools and Securities Lending, Repurchases and Reverse Repurchases by Investment Funds
The comment period ends on June 25, 2013. - CSA Notice - CSA Notice of Amendments to National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations and to Companion Policy 31-103CP Registration Requirements, Exemptions and Ongoing Registrant Obligations (Cost Disclosure, Performance Reporting and Client Statement
CSA Notice of amendments to National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations and Companion Policy 31-103CP Registration Requirements, Exemptions and Ongoing Registrant Obligations relating to cost disclosure, performance reporting and client statements, which will come into force on July 15, 2013. - CSA Staff Notice 13-318 - Changes to www.SEDAR.com
This notice announces the changes to the SEDAR website to be implemented on April 6, 2013.
News and Events
- News release 2013/18 - Canadian Securities Administrators announce March 26 as Check Registration Day
- News release 2013/19 - Canadian Securities Regulators seek comment on proposals to modernize investment fund rules
- News release 2013/20 - Canadian Securities Regulators implement disclosure requirements for investment costs and performance
Decisions, Settlements, Hearings, and Temporary Orders
(Enforcement)
- No new documents
Cease Trade Orders and Revocations
(Failure to File)
- Mission Ready Services Inc. - Revocation Order
- Balaton Power Inc. - Revocation Order
Exemption Orders
- FAM Real Estate Investment Trust - Decision
- Aquinox Pharmaceuticals Inc. and Aquinox Pharmaceuticals (USA) Inc. - Exemption Order